By Editorial TeamEveryone’s racing to cram Artificial Intelligence (AI) into healthcare to fix diagnostics or personalize care. But in the gold rush, people are skipping the most important part: vetting the vendors. By 2026, a flimsy due diligence process for AI health vendors will become a source of massive operational, financial, and ethical disasters. When a misdiagnosis from a bad algorithm leads to a lawsuit, or a data breach hits the front page, it will be too late to ask if the vetting process was good enough.
Key Takeaways
- Get your hands dirty with a vendor’s data governance. Verify their data acquisition, storage, and usage policies actually line up with HIPAA and other privacy regulations, don’t just take their word for it.
- Force the vendor to be completely transparent about their AI model’s training data. You need to see the demographics and know about potential biases before you buy, so you can head off the risk of algorithmic discrimination.
- Write continuous model monitoring and retraining into the contract. AI systems must be adapted to new clinical data to maintain their performance, and you need to know who is responsible and who pays.
- Audit the vendor’s cybersecurity, specifically for AI vulnerabilities like adversarial attacks or data poisoning. Use an independent third party. Don’t rely on the vendor’s internal reports.
- Don’t buy an algorithm without proof it works. Demand to see the peer-reviewed studies and real-world performance data before you let it anywhere near a patient workflow.
“You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.”
Overlooking Data Governance and Privacy Protocols
Glancing at data governance is the most common mistake in AI health vendor diligence. Healthcare data is what these AI systems eat, and they eat a lot of it. Organizations think checking the HIPAA compliance box is enough, but that’s just the floor. The real work is figuring out exactly how a vendor gets, uses, stores, and protects data for the entire life of the AI.
A classic screw-up is failing to question where the training data came from. Was it sourced ethically? Does it even look like your patient population? A 2025 report from the Healthcare Information and Management Systems Society (HIMSS) found that 30% of healthcare organizations had worries about the source and bias of vendor-supplied training data. Letting this slide means you could end up with an AI model that’s garbage for your patients, or worse, one that makes existing health disparities even bigger. An algorithm trained mostly on one demographic can easily misdiagnose or suggest the wrong treatment for another. You need to get explicit documentation on their data acquisition methods, anonymization practices, and how long they keep the data. It’s also smart to ask about their data minimization, are they collecting only what’s absolutely necessary?
And it’s not just privacy. You have to think about data sovereignty, especially if you’re dealing with a global vendor. Where is your data actually being stored? Will it cross borders? The U.S. Department of Health & Human Services (HHS) has plenty of guidance on HIPAA, but the specifics of AI data flows require a much deeper investigation. You should also be asking to see the vendor’s specific incident response plan for a data breach that involves their AI system. A generic IT security plan won’t cover the unique mess of a compromised AI model and its corrupted outputs.
Insufficient Transparency in AI Model Design and Validation
Another huge mistake is letting vendors sell you a “black box.” They love to call their AI proprietary, which is often a cover for not wanting to explain how it works. This is a non-starter in a clinical setting, where a doctor’s trust is everything. How can any clinician be expected to act on an AI’s recommendation if they have no idea how it reached its conclusion?
Your diligence has to tear apart the model’s design, the algorithms, the features it weighs, and its entire decision-making process. Ask for the detailed architecture documents. Most importantly, grill them on how it was validated. A vendor claiming “high accuracy” means nothing. That’s just marketing. You need to see the specific validation metrics (like sensitivity, specificity, PPV, and NPV), the exact datasets used for testing, and the full methodology. The American Medical Association (AMA) said as much in a 2024 policy statement, calling for transparent and explainable AI as an ethical requirement.
Good vendors will have evidence of independent clinical validation, ideally from peer-reviewed studies in real medical journals. If they don’t have those, then you should ask for the raw validation data so your own clinical experts can look it over. It’s also critical to see how the model performs on different patient subgroups to sniff out any potential biases or weak spots. This isn’t just about being difficult. It’s about making sure you’re buying a tool based on science, not a sales pitch. If a vendor is cagey about this level of scrutiny, that’s a major red flag.
Neglecting Post-Deployment Monitoring and Maintenance
The work isn’t over once the AI is deployed. It’s just beginning. A lot of people treat AI like any other piece of software, which is a fundamental error. Models “drift.” Their performance degrades over time because the real world changes. New diseases, new treatment protocols, and shifting patient demographics can all make a once-accurate AI model useless or even dangerous.
Good due diligence means getting a clear picture of the vendor’s plan for post-deployment life. What’s the plan to detect performance degradation? How often will the model be re-evaluated and retrained, and who is on the hook for the cost and effort? The U.S. Food and Drug Administration (FDA) guidance on AI/ML-based software as a medical device (SaMD) talks about a “total product lifecycle” approach, and that includes this kind of continuous monitoring. Your contract has to spell all this out, including service level agreements (SLAs) for model updates and fixes.
You also need to think about version control. What happens if an update breaks something? Can you roll it back to a previous, stable version? What’s their process for communicating changes to the model and the potential impact on your clinical workflows? Without a solid post-deployment strategy, that big AI investment can quickly become a liability spitting out bad advice. This is where organizations trying to move fast often get into trouble, making the fatal assumption that the vendor will take care of everything. They won’t, not unless you make them.
Underestimating Integration Complexity and Workflow Impact
Plugging a new AI tool into a hospital’s IT setup is almost always a painful, complicated process, yet organizations constantly underestimate it. A huge mistake is failing to properly vet a vendor’s actual integration capabilities and what the tool will do to your clinical workflows. A technically brilliant AI tool is worthless if it doesn’t fit into the daily grind of your staff.
You have to assess the vendor’s track record of integrating with your specific EHR, whether it’s Epic Systems’ EpicCare Inpatient or Cerner Corporation’s Millennium EHR. Do they have standard APIs or is it all custom development? Custom work is a magnet for cost overruns and bugs. Get detailed integration plans and demand references from other providers who have integrated the same tool with a similar setup. It’s no surprise that in a late 2025 College of Healthcare Information Management Executives (CHIME) survey, 45% of CIOs said integration problems were a top reason they struggled with AI.
Even if the tech integrates, you have to think about the people. How does this tool change a clinician’s day? Does it add clicks and alerts, or does it actually save time? Does it require a ton of retraining? Run a pilot program or simulation to see what actually happens in the real world before you sign a massive contract. An AI tool that’s a pain to use will cause clinician burnout and get ignored, completely wasting the investment. People get so focused on the algorithm they forget about the human who has to use it.
The promise of AI in healthcare is real, but you have to walk in with your eyes open. If you sidestep the common mistakes in data governance, transparency, post-deployment care, and integration, you can actually find AI solutions that enhance patient care instead of causing headaches. The key is a complete evaluation that goes past the tech specs and looks hard at the ethical, operational, and long-term financial realities.
What is the most critical aspect of AI health vendor due diligence?
It’s the data. The single most critical part is tearing apart the vendor’s data governance. This means looking at everything from how they acquire and process data to where they store it and how they secure it, making sure they truly meet privacy rules like HIPAA and aren’t just saying they do. You have to verify that their training data is ethically sourced and actually representative of your patients.
Why is transparency in AI models important for healthcare?
Because doctors won’t use what they don’t trust. Transparency lets clinicians see the ‘why’ behind an AI’s recommendation which is essential for building that trust. It’s also the only way to spot and correct for hidden biases that could lead to the model performing poorly for certain patient groups.
How frequently should AI models in healthcare be monitored and updated?
Constantly. AI models need continuous monitoring to watch for performance “drift” as real-world data changes. They should be re-evaluated and potentially retrained on a regular schedule. There’s no single magic number for frequency, it depends on the application, but your contract with the vendor must explicitly define this schedule and who is responsible for doing the work and paying for it.
What are the risks of poor AI integration into existing EHR systems?
Poor integration creates chaos. It can disrupt clinical workflows, pile more administrative work onto already burned-out clinicians, create data silos, and cause errors when transferring patient information. In the end, a badly integrated tool won’t deliver any of its promised benefits and will likely create new patient safety risks and staff dissatisfaction.
Should healthcare organizations rely solely on a vendor’s self-reported validation data?
Absolutely not. Never trust a vendor’s own homework without checking it. You must demand proof of independent clinical validation, like peer-reviewed studies. Better yet, run your own internal review or a pilot program to see for yourself how the AI performs with your own patients and in your own clinical environment.
